IL124279A - Transdermal therapeutic systems containing hmg-coa reductase inhibitors - Google Patents
Transdermal therapeutic systems containing hmg-coa reductase inhibitorsInfo
- Publication number
- IL124279A IL124279A IL12427997A IL12427996A IL124279A IL 124279 A IL124279 A IL 124279A IL 12427997 A IL12427997 A IL 12427997A IL 12427996 A IL12427996 A IL 12427996A IL 124279 A IL124279 A IL 124279A
- Authority
- IL
- Israel
- Prior art keywords
- coa reductase
- reductase inhibitors
- transdermal therapeutic
- systems containing
- therapeutic systems
- Prior art date
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title abstract 2
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19541260A DE19541260A1 (de) | 1995-11-06 | 1995-11-06 | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut |
| PCT/EP1996/004138 WO1997017061A1 (de) | 1995-11-06 | 1996-09-21 | Therapeutische zubereitung zur transdermalen applikation von wirkstoffen durch die haut |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL124279A true IL124279A (en) | 2003-07-06 |
Family
ID=7776710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12427997A IL124279A (en) | 1995-11-06 | 1996-09-21 | Transdermal therapeutic systems containing hmg-coa reductase inhibitors |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6379696B1 (de) |
| EP (1) | EP0859595B1 (de) |
| JP (1) | JP2001507331A (de) |
| KR (1) | KR100445940B1 (de) |
| CN (1) | CN1201385A (de) |
| AT (1) | ATE186209T1 (de) |
| AU (1) | AU716896B2 (de) |
| CZ (1) | CZ289143B6 (de) |
| DE (2) | DE19541260A1 (de) |
| ES (1) | ES2141534T3 (de) |
| GR (1) | GR3032523T3 (de) |
| IL (1) | IL124279A (de) |
| MX (1) | MX9803563A (de) |
| MY (1) | MY132407A (de) |
| NO (1) | NO982006L (de) |
| NZ (1) | NZ318783A (de) |
| PL (1) | PL326497A1 (de) |
| PT (1) | PT859595E (de) |
| SK (1) | SK281405B6 (de) |
| WO (1) | WO1997017061A1 (de) |
| ZA (1) | ZA969271B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19830732B4 (de) * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung |
| EP1335711B1 (de) * | 2000-09-08 | 2007-07-25 | Alza Corporation | Transdermale vorrichtung |
| US20020187169A1 (en) * | 2001-05-11 | 2002-12-12 | Shoujun Chen | Kavalactone compositions |
| JP2007500711A (ja) * | 2003-07-28 | 2007-01-18 | アルザ・コーポレーシヨン | 経皮的ワーファリン−含有送達システム |
| CN1938012A (zh) * | 2004-03-31 | 2007-03-28 | 兴和株式会社 | 外用剂 |
| ES2385752T3 (es) | 2006-04-26 | 2012-07-31 | Rosemont Pharmaceuticals Ltd | Composiciones orales líquidas |
| US7803778B2 (en) | 2006-05-23 | 2010-09-28 | Theracos, Inc. | Glucose transport inhibitors and methods of use |
| US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
| US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
| US7652767B2 (en) * | 2006-10-19 | 2010-01-26 | Sporian Microsystems, Inc. | Optical sensor with chemically reactive surface |
| US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
| WO2008115224A2 (en) * | 2007-03-20 | 2008-09-25 | Bayer Healthcare Llc | Method of analyzing an analyte |
| CN104803957A (zh) | 2007-04-02 | 2015-07-29 | 泰拉科斯有限公司 | 苄基化糖苷衍生物及其用法 |
| WO2009026537A1 (en) | 2007-08-23 | 2009-02-26 | Theracos, Inc. | Benzylbenzene derivatives and methods of use |
| WO2010009243A1 (en) | 2008-07-15 | 2010-01-21 | Theracos, Inc. | Deuterated benzylbenzene derivatives and methods of use |
| PT2324002T (pt) | 2008-08-22 | 2016-11-09 | Theracos Sub Llc | Processos para a preparação de inibidores de sglt2 |
| AU2009324894B2 (en) | 2008-11-25 | 2015-04-09 | University Of Rochester | MLK inhibitors and methods of use |
| EP2445506B1 (de) | 2009-06-24 | 2014-12-31 | Entarco SA | Die verwendung von spinosyn und spinosyn enthaltenden zubereitungen zur behandlung von protozoen verursachten erkrankungen, von viralen infektionen und von krebs. |
| KR20150036825A (ko) | 2010-04-13 | 2015-04-07 | 나지브 바불 | 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법 |
| CA2800176C (en) | 2010-05-24 | 2018-08-28 | University Of Rochester | Bicyclic heteroaryl kinase inhibitors and methods of use |
| WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
| EP2654757A1 (de) | 2010-12-22 | 2013-10-30 | Entarco SA | Verwendung von spinosynen und spinosynzusammensetzungen als lokalanästhetika und antiarrhythmika |
| US9592288B2 (en) | 2011-02-18 | 2017-03-14 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
| CN104884059B (zh) | 2012-11-30 | 2018-08-10 | 罗切斯特大学 | 用于hiv/aids治疗的混合谱系激酶抑制剂 |
| US9420820B2 (en) | 2013-08-09 | 2016-08-23 | University Of Tsukuba | Method for isolating polyphenols from olive mill water |
| JP6566444B2 (ja) | 2014-03-19 | 2019-08-28 | カーザ グローバル エルエルシーＣｕｒｚａ Ｇｌｏｂａｌ， Ｌｌｃ | ２−（アシルアミノ）イミダゾールを含む組成物および方法 |
| JP2020512981A (ja) | 2017-03-31 | 2020-04-30 | カーザ グローバル，リミティド ライアビリティ カンパニー | 置換２−アミノイミダゾールを含む組成物と方法 |
| BR112021003156A2 (pt) | 2018-08-23 | 2021-05-11 | Seagen, Inc. | composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit. |
| JP2023548538A (ja) | 2020-11-08 | 2023-11-17 | シージェン インコーポレイテッド | 併用療法 |
| WO2022217026A1 (en) | 2021-04-09 | 2022-10-13 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
| WO2024191807A1 (en) | 2023-03-10 | 2024-09-19 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3634016A1 (de) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung |
| US5211947A (en) * | 1988-12-16 | 1993-05-18 | Schering Corporation | Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
| US5316765A (en) * | 1989-09-07 | 1994-05-31 | Karl Folkers Foundation For Biomedical And Clinical Research | Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies |
| DE69122464T2 (de) * | 1990-03-30 | 1997-02-20 | Yasunori Morimoto | Transdermal absorbierbares mittel mit morphin hydrochlorid |
| IL109037A (en) * | 1993-03-19 | 1999-01-26 | Cellegy Pharma Inc | Preparations for causing phase separation of lipid layers and preparation of the above preparations |
| DE4341444C2 (de) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
| US5968983A (en) * | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
-
1995
- 1995-11-06 DE DE19541260A patent/DE19541260A1/de not_active Withdrawn
-
1996
- 1996-09-21 CN CN96198113A patent/CN1201385A/zh active Pending
- 1996-09-21 NZ NZ318783A patent/NZ318783A/en unknown
- 1996-09-21 JP JP51777797A patent/JP2001507331A/ja active Pending
- 1996-09-21 PT PT96931820T patent/PT859595E/pt unknown
- 1996-09-21 AT AT96931820T patent/ATE186209T1/de active
- 1996-09-21 ES ES96931820T patent/ES2141534T3/es not_active Expired - Lifetime
- 1996-09-21 SK SK558-98A patent/SK281405B6/sk unknown
- 1996-09-21 EP EP96931820A patent/EP0859595B1/de not_active Expired - Lifetime
- 1996-09-21 CZ CZ19981366A patent/CZ289143B6/cs not_active IP Right Cessation
- 1996-09-21 AU AU70859/96A patent/AU716896B2/en not_active Ceased
- 1996-09-21 PL PL96326497A patent/PL326497A1/xx unknown
- 1996-09-21 US US09/068,326 patent/US6379696B1/en not_active Expired - Lifetime
- 1996-09-21 IL IL12427997A patent/IL124279A/xx not_active IP Right Cessation
- 1996-09-21 WO PCT/EP1996/004138 patent/WO1997017061A1/de not_active Ceased
- 1996-09-21 KR KR10-1998-0703316A patent/KR100445940B1/ko not_active Expired - Fee Related
- 1996-09-21 DE DE59603597T patent/DE59603597D1/de not_active Expired - Lifetime
- 1996-11-04 MY MYPI96004590A patent/MY132407A/en unknown
- 1996-11-05 ZA ZA969271A patent/ZA969271B/xx unknown
-
1998
- 1998-05-04 NO NO982006A patent/NO982006L/no not_active Application Discontinuation
- 1998-05-06 MX MX9803563A patent/MX9803563A/es not_active IP Right Cessation
-
2000
- 2000-01-31 GR GR20000400219T patent/GR3032523T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3032523T3 (en) | 2000-05-31 |
| EP0859595A1 (de) | 1998-08-26 |
| CN1201385A (zh) | 1998-12-09 |
| US6379696B1 (en) | 2002-04-30 |
| WO1997017061A1 (de) | 1997-05-15 |
| DE59603597D1 (de) | 1999-12-09 |
| SK281405B6 (sk) | 2001-03-12 |
| PT859595E (pt) | 2000-04-28 |
| NO982006D0 (no) | 1998-05-04 |
| KR100445940B1 (ko) | 2005-09-30 |
| CZ289143B6 (cs) | 2001-11-14 |
| AU7085996A (en) | 1997-05-29 |
| DE19541260A1 (de) | 1997-05-07 |
| ZA969271B (en) | 1997-06-03 |
| PL326497A1 (en) | 1998-09-28 |
| MY132407A (en) | 2007-10-31 |
| SK55898A3 (en) | 1998-11-04 |
| NZ318783A (en) | 1999-04-29 |
| NO982006L (no) | 1998-05-04 |
| MX9803563A (es) | 1998-09-30 |
| ES2141534T3 (es) | 2000-03-16 |
| JP2001507331A (ja) | 2001-06-05 |
| KR19990067320A (ko) | 1999-08-16 |
| CZ136698A3 (cs) | 1998-07-15 |
| EP0859595B1 (de) | 1999-11-03 |
| AU716896B2 (en) | 2000-03-09 |
| ATE186209T1 (de) | 1999-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7085996A (en) | Therapeutic preparation for the transdermal application of active substances through the skin | |
| EP0316065A3 (en) | Improved transdermal drug delivery device | |
| IE820296L (en) | Dosage form for coadministering a drug and a percutaneous¹absorption enhancer | |
| AU4923500A (en) | Device and method for increasing the transdermal permeation of medicaments | |
| AU533491B2 (en) | Bandage for administering drugs to the skin | |
| NO980700D0 (no) | Perifert aktive anti-hyperalgesi opiater | |
| IE46069L (en) | Adhesive skin patch | |
| AU2895392A (en) | Transdermal therapeutic systems containing crystallization inhibitors | |
| AU5323398A (en) | Contour of a transdermal therapeutic system | |
| CA2132369A1 (en) | Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances | |
| BR0215102A (pt) | Transporte transdermal de compostos, formulação tópica, método para melhorar a absorção da pele, método para a terapia de reposição hormonal, uso de um ou mais derivados de fosfato de um composto hidróxi farmacêutico em um sistema de aplicação transdermal, sistema de aplicação transdermal, método para aplicação de um composto hidróxi farmacêutico a um indivìduo e para melhorar a eficácia de uma formulação | |
| IL106512A (en) | Plaster for the transdermal application of steroid hormones and process for the preparation thereof | |
| DE69731882D1 (de) | Transdermal verabreichtes dextromethorphan als hustenmittel | |
| NZ509215A (en) | Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels | |
| TWI256892B (en) | Plasminogen activator inhibitor and external preparation for skin comprising the same | |
| MX9701968A (es) | Emplasto de escopolamina. | |
| EP0693479A4 (de) | Neue aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel | |
| NZ502405A (en) | Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin | |
| WO2001041771A3 (de) | Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne | |
| CA2235617A1 (en) | Therapeutic preparation for the transdermal administration of active substances | |
| WO1996027384A3 (en) | Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase | |
| PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances | |
| AU1290797A (en) | Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation | |
| NO924926L (no) | Transdermal administrering av buprenorfin | |
| HK1026846A (en) | Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |